Effects of 4 y of oral supplementation with β-carotene on serum concentrations of retinol, tocopherol, and five carotenoids

American Journal of Clinical Nutrition

Volumn 66, Issue 2, 1997, Pages 315-319

  Nierenberg, David W ^a,b   Dain, Bradley J ^a   Mott, Leila A ^a   Baron, John A ^a   Greenberg, E Robert ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Cryptoxanthin; Lutein; Lycopene; Retinol; Supplementation; Zeaxanthin; carotene; tocopherol; Carotene

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; BETA CAROTENE; CRYPTOXANTHIN; LYCOPENE; RETINOL; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; COLON ADENOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL;

EID: 0030742249     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.2.315     Document Type: Article

References (27)

1. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985;45: 1-8.
2. Menkes MS, Comstock GW, Vuilleumier JP, et al. Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer. N Engl J Med 1986;315:1250-4.
3. Malone WF. Studies evaluating antioxidants and beta-carotene as chemopreventives. Am J Clin Nutr 1991;53(suppl):305S-13S.
4. Kardinaal AF, Kok FJ, Ringstad J, et al. Antioxidants in adipose tissue and risk of myocardial infarction. Lancet 1993;342:1379-84.
5. Gaziano JM, Hennekens CH. The role of beta-carotene in the prevention of cardiovascular disease. Ann N Y Acad Sci 1994;691:148-55.
6. van Poppel G, Goldbohm RA. Epidemiologic evidence for beta-carotene and cancer prevention. Am J Clin Nutr 1995;62(suppl): 1393S-402S.
7. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease: a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860-72.
8. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
9. Meyskens FL. Coming of age[emdash]the chemoprevention of cancer. N Engl J Med 1990;323:825-7.
10. Xu MJ, Peng YM, Liu Y, et al. Effect of chronic oral administration of beta-carotene on plasma alpha-tocopherol concentrations in normal subjects. Proc Am Assoc Cancer Res 1990;31:126 (abstr).
11. Xu MJ, Plezia PM, Alberts DS, et al: Reduction in plasma or skin alpha-tocopherol concentration with long-term oral administration of beta-carotene in humans and mice. J Natl Cancer Inst 1992;84: 1559-65.
12. Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER. Determinants of increase in plasma concentration of β-carotene after chronic oral supplementation. Skin Cancer Prevention Study Group. Am J Clin Nutr 1991;53:1443-9.
13. Micozzi MS, Brown ED, Edwards BK, et al. Plasma carotenoid response to chronic intake of selected foods and β-carotene supplements in men. Am J Clin Nutr 1992;55:1120-5.
14. Willett WC, Stampfer MJ, Underwood BA, Taylor JO, Hennekens CH. Vitamins A, E, and carotene: effects of supplementation on their plasma levels. Am J Clin Nutr 1983;38:559-66.
15. Albanes D, Virtamo J, Rautalahti M, et al. Serum beta-carotene before and after beta-carotene supplementation. Eur J Clin Nutr 1992;46: 15-24.
16. Nierenberg DW, Stukel TA, Mott LA, Greenberg ER. Steady-state serum concentration of alpha-tocopherol not altered by supplementation with oral beta-carotene. J Natl Cancer Inst 1994;86:117-20.
17. Wahlqvist ML, Wattanapenpaiboon N, Macrae FA, Lambert JR, MacLennan R, Hsu-Hage BH. Changes in serum carotenoids in subjects with colorectal adenomas after 24 mo of β-carotene supplementation. Australian Polyp Prevention Project Investigators. Am J Clin Nutr 1994;60:936-43.
18. Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-7.
19. Nierenberg DW. Serum and plasma beta-carotene levels measured with an improved method of high-performance liquid chromatography. J Chromatogr 1985;339:273-84.
20. Nierenberg DW, Nann SL. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr 1992;56:417-26.
21. Weisberg S. Applied linear regression. New York: John Wiley & Sons, 1980.
22. Lehmann EL. Nonparametrics. Statistical methods based on ranks. San Francisco: Holden Day, 1975.
23. Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER. Determinants of plasma levels of beta-carotene and retinol. Skin Cancer Prevention Study Group. Am J Epidemiol 1989;130:511-21.
24. Costantino JP, Kuller LH, Begg L, Redmond CK, Bates MW. Serum level changes after administration of a pharmacologic dose of β-carotene. Am J Clin Nutr 1988;48:1277-83.
25. Nierenberg DW, Peng YM, Alberts DS. Methods for the determination of retinoids, alpha-tocopherol, and carotenoids in human serum, plasma, and other tissues. In: Micozzi M, Moon T, eds. Nutrition and cancer prevention: the role of micronutrients. New York: Marcel Dekker, 1989:181-209.
26. Cantilena LR, Stukel TA, Greenberg ER, Nann S, Nierenberg DW. Diurnal and seasonal variation of five carotenoids measured in human serum. Am J Clin Nutr 1992;55:659-63.
27. Nierenberg DW, Stukel TA. Diurnal variation in plasma levels of retinol, tocopherol, and beta-carotene. Am J Med Sci 1987;294:187-90.